鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/05/29 | 2,767 | 2,772 | 2,728 | 2,728 | -31 | -1.1% | 12,300 |
2017/05/26 | 2,823 | 2,823 | 2,755 | 2,759 | -63 | -2.2% | 27,300 |
2017/05/25 | 2,848 | 2,848 | 2,815 | 2,822 | -26 | -0.9% | 24,100 |
2017/05/24 | 2,838 | 2,849 | 2,831 | 2,848 | +13 | +0.5% | 27,000 |
2017/05/23 | 2,857 | 2,861 | 2,835 | 2,835 | -22 | -0.8% | 17,000 |
2017/05/22 | 2,849 | 2,899 | 2,849 | 2,857 | -4 | -0.1% | 14,000 |
2017/05/19 | 2,877 | 2,886 | 2,841 | 2,861 | -21 | -0.7% | 27,600 |
2017/05/18 | 2,866 | 2,892 | 2,866 | 2,882 | -34 | -1.2% | 25,200 |
2017/05/17 | 2,932 | 2,933 | 2,904 | 2,916 | -41 | -1.4% | 27,200 |
2017/05/16 | 2,922 | 2,961 | 2,922 | 2,957 | +18 | +0.6% | 23,700 |
2017/05/15 | 2,903 | 2,969 | 2,903 | 2,939 | +20 | +0.7% | 35,400 |
2017/05/12 | 2,946 | 2,946 | 2,901 | 2,919 | -15 | -0.5% | 35,900 |
2017/05/11 | 2,916 | 2,971 | 2,916 | 2,934 | +5 | +0.2% | 55,400 |
2017/05/10 | 2,896 | 2,929 | 2,881 | 2,929 | +53 | +1.8% | 41,800 |
2017/05/09 | 2,833 | 2,883 | 2,831 | 2,876 | +21 | +0.7% | 33,600 |
2017/05/08 | 2,778 | 2,858 | 2,778 | 2,855 | +80 | +2.9% | 49,000 |
2017/05/02 | 2,734 | 2,779 | 2,734 | 2,775 | +50 | +1.8% | 32,800 |
2017/05/01 | 2,719 | 2,732 | 2,683 | 2,725 | +15 | +0.6% | 44,800 |
2017/04/28 | 2,836 | 2,840 | 2,705 | 2,710 | -176 | -6.1% | 129,500 |
2017/04/27 | 2,854 | 2,900 | 2,854 | 2,886 | +8 | +0.3% | 20,200 |
2017/04/26 | 2,851 | 2,887 | 2,850 | 2,878 | +14 | +0.5% | 23,000 |
2017/04/25 | 2,877 | 2,877 | 2,841 | 2,864 | -2 | -0.1% | 23,900 |
2017/04/24 | 2,850 | 2,878 | 2,837 | 2,866 | +48 | +1.7% | 20,100 |
2017/04/21 | 2,782 | 2,820 | 2,774 | 2,818 | +36 | +1.3% | 13,300 |
2017/04/20 | 2,787 | 2,794 | 2,762 | 2,782 | -17 | -0.6% | 19,700 |
2017/04/19 | 2,801 | 2,839 | 2,799 | 2,799 | -34 | -1.2% | 15,800 |
2017/04/18 | 2,840 | 2,852 | 2,813 | 2,833 | +4 | +0.1% | 18,700 |
2017/04/17 | 2,780 | 2,836 | 2,780 | 2,829 | +28 | +1% | 9,300 |
2017/04/14 | 2,814 | 2,834 | 2,792 | 2,801 | -57 | -2% | 25,800 |
2017/04/13 | 2,805 | 2,858 | 2,805 | 2,858 | +20 | +0.7% | 30,800 |
2017/04/12 | 2,810 | 2,841 | 2,799 | 2,838 | -6 | -0.2% | 23,900 |
2017/04/11 | 2,851 | 2,880 | 2,834 | 2,844 | +1 | ±0% | 32,200 |
2017/04/10 | 2,880 | 2,889 | 2,837 | 2,843 | -30 | -1% | 38,600 |
2017/04/07 | 2,842 | 2,899 | 2,835 | 2,873 | +14 | +0.5% | 32,700 |
2017/04/06 | 2,880 | 2,889 | 2,852 | 2,859 | -47 | -1.6% | 39,500 |
2017/04/05 | 2,881 | 2,923 | 2,881 | 2,906 | +18 | +0.6% | 28,600 |
2017/04/04 | 2,895 | 2,914 | 2,866 | 2,888 | -23 | -0.8% | 57,500 |
2017/04/03 | 2,872 | 2,936 | 2,861 | 2,911 | +39 | +1.4% | 76,000 |
2017/03/31 | 2,923 | 2,943 | 2,872 | 2,872 | -63 | -2.1% | 42,200 |
2017/03/30 | 2,957 | 2,970 | 2,917 | 2,935 | -32 | -1.1% | 33,100 |
2017/03/29 | 2,959 | 2,978 | 2,925 | 2,967 | +31 | +1.1% | 44,300 |
2017/03/28 | 2,886 | 2,936 | 2,872 | 2,936 | +86 | +3% | 32,700 |
2017/03/27 | 2,923 | 2,926 | 2,845 | 2,850 | -111 | -3.7% | 63,900 |
2017/03/24 | 2,955 | 2,964 | 2,918 | 2,961 | +13 | +0.4% | 29,600 |
2017/03/23 | 2,925 | 2,952 | 2,910 | 2,948 | +35 | +1.2% | 34,000 |
2017/03/22 | 2,911 | 2,943 | 2,898 | 2,913 | -43 | -1.5% | 34,000 |
2017/03/21 | 2,945 | 2,964 | 2,938 | 2,956 | -2 | -0.1% | 23,800 |
2017/03/17 | 2,973 | 2,996 | 2,929 | 2,958 | -42 | -1.4% | 44,600 |
2017/03/16 | 2,967 | 3,010 | 2,967 | 3,000 | +10 | +0.3% | 38,400 |
2017/03/15 | 2,972 | 2,995 | 2,965 | 2,990 | +7 | +0.2% | 18,800 |
1951~
2000
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム